News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncClub: Join the Chat on Trending Trials in Cancer
| In-person and virtual events just for HCPs

Perspectives on Metastatic Kidney Cancer

home / peer-exchange / metastatic-kidney-cancer
Prognostic and Predictive Factors in Renal Cell Carcinoma

EP. 1: Prognostic and Predictive Factors in Renal Cell Carcinoma

January 29th 2016
Treating Intermediate and Favorable-Risk RCC

EP. 2: Treating Intermediate and Favorable-Risk RCC

January 29th 2016
Reviewing Results from COMPARZ and PISCES Clinical Trials

EP. 3: Reviewing Results from COMPARZ and PISCES Clinical Trials

January 29th 2016
Dosing Sunitinib and Pazopanib in Renal Cell Carcinoma

EP. 4: Dosing Sunitinib and Pazopanib in Renal Cell Carcinoma

January 29th 2016
Bone and Brain Metastases in Renal Cell Carcinoma

EP. 5: Bone and Brain Metastases in Renal Cell Carcinoma

January 29th 2016
Treating Non-Clear Cell Renal Cell Carcinoma

EP. 6: Treating Non-Clear Cell Renal Cell Carcinoma

January 29th 2016
Managing Disease Progression in RCC

EP. 7: Managing Disease Progression in RCC

January 29th 2016
Selecting Second-Line Agents in Renal Cell Carcinoma

EP. 8: Selecting Second-Line Agents in Renal Cell Carcinoma

January 29th 2016
Predictive Tools in Renal Cell Carcinoma

EP. 9: Predictive Tools in Renal Cell Carcinoma

January 29th 2016
Clinical Trial Data Review: Nivolumab Use in RCC

EP. 10: Clinical Trial Data Review: Nivolumab Use in RCC

January 29th 2016
Trial Data on Cabozantinib in Renal Cell Carcinoma

EP. 11: Trial Data on Cabozantinib in Renal Cell Carcinoma

January 29th 2016
PD-L1 Expression as a Biomarker in RCC

EP. 12: PD-L1 Expression as a Biomarker in RCC

January 29th 2016
Study Results: Lenvatinib in Renal Cell Carcinoma

EP. 13: Study Results: Lenvatinib in Renal Cell Carcinoma

January 29th 2016
Vaccines for Renal Cell Carcinoma

EP. 14: Vaccines for Renal Cell Carcinoma

January 29th 2016
Advancing Renal Cell Carcinoma

EP. 15: Advancing Renal Cell Carcinoma

January 29th 2016

Latest Conference Coverage

Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors

Navigating Systemic Therapy for RCC: Balancing Risk Status and Response

ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC

Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact